{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:07:55Z","timestamp":1792138075808,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,10,31]],"date-time":"2010-10-31T00:00:00Z","timestamp":1288483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/nchembio.466","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T15:05:16Z","timestamp":1289833516000},"page":"907-913","source":"Crossref","is-referenced-by-count":228,"title":["Ultrasensitive in situ visualization of active glucocerebrosidase molecules"],"prefix":"10.1038","volume":"6","author":[{"given":"Martin D","family":"Witte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter W","family":"Kallemeijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Aten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah-Yee","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Strijland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma E","family":"Donker-Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianus M C H","family":"van den Nieuwendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Bleijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertjan","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan I","family":"Florea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Hooibrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E M","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelof","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf G","family":"Boot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijsbert A","family":"van der Marel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman S","family":"Overkleeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M F G","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,31]]},"reference":[{"key":"BFnchembio466_CR1","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1172\/JCI105417","volume":"45","author":"RO Brady","year":"1966","unstructured":"Brady, R.O., Kanfer, J.N., Bradley, R.M. & Shapiro, D. Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J. Clin. Invest. 45, 1112\u20131115 (1966).","journal-title":"J. Clin. Invest."},{"key":"BFnchembio466_CR2","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","volume":"372","author":"GA Grabowski","year":"2008","unstructured":"Grabowski, G.A. Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet 372, 1263\u20131271 (2008).","journal-title":"Lancet"},{"key":"BFnchembio466_CR3","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/archneur.65.10.1353","volume":"65","author":"O Goker-Alpan","year":"2008","unstructured":"Goker-Alpan, O. et al. The spectrum of Parkinsonian manifestations associated with glucocerebrosidase mutations. Arch. Neurol. 65, 1353\u20131357 (2008).","journal-title":"Arch. Neurol."},{"key":"BFnchembio466_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0925-4439(91)90066-I","volume":"1096","author":"S Van Weely","year":"1991","unstructured":"Van Weely, S. et al. Clinical genotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts. Biochim. Biophys. Acta 1096, 301\u2013311 (1991).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnchembio466_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/qjmed\/hch036","volume":"97","author":"RH Lachmann","year":"2004","unstructured":"Lachmann, R.H., Grant, I.R., Halsall, D. & Cox, T.M. Twin pairs showing discordance of phenotype in adult Gaucher's disease. QJM 97, 199\u2013204 (2004).","journal-title":"QJM"},{"key":"BFnchembio466_CR6","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","volume":"324","author":"NW Barton","year":"1991","unstructured":"Barton, N.W. et al. Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease. N. Engl. J. Med. 324, 1464\u20131470 (1991).","journal-title":"N. Engl. J. Med."},{"key":"BFnchembio466_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","volume":"122","author":"GA Grabowski","year":"1995","unstructured":"Grabowski, G.A. et al. Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann. Intern. Med. 122, 33\u201339 (1995).","journal-title":"Ann. Intern. Med."},{"key":"BFnchembio466_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","volume":"29","author":"JM Aerts","year":"2006","unstructured":"Aerts, J.M., Hollak, C.E., Boot, R.G., Groener, J.E. & Maas, M. Substrate reduction therapy of glycosphingolipid storage disorders. J. Inherit. Metab. Dis. 29, 449\u2013456 (2006).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFnchembio466_CR9","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","volume":"269","author":"FM Platt","year":"1994","unstructured":"Platt, F.M., Neises, G.R., Dwek, R.A. & Butters, T.D. N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J. Biol. Chem. 269, 8362\u20138365 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio466_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1432-1033.1987.tb11008.x","volume":"164","author":"LMV Jonsson","year":"1987","unstructured":"Jonsson, L.M.V. et al. Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts. Eur. J. Biochem. 164, 171\u2013179 (1987).","journal-title":"Eur. J. Biochem."},{"key":"BFnchembio466_CR11","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/S0021-9258(19)67845-2","volume":"266","author":"T Ohashi","year":"1991","unstructured":"Ohashi, T. et al. Characterization of human glucocerebrosidase from different mutant alleles. J. Biol. Chem. 266, 3661\u20133667 (1991).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio466_CR12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","volume":"12","author":"AR Sawkar","year":"2005","unstructured":"Sawkar, A.R. et al. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles. Chem. Biol. 12, 1235\u20131244 (2005).","journal-title":"Chem. Biol."},{"key":"BFnchembio466_CR13","doi-asserted-by":"publisher","first-page":"15428","DOI":"10.1073\/pnas.192582899","volume":"99","author":"AR Sawkar","year":"2002","unstructured":"Sawkar, A.R. et al. Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease. Proc. Natl. Acad. Sci. USA 99, 15428\u201315433 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio466_CR14","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","volume":"14","author":"I Ron","year":"2005","unstructured":"Ron, I. & Horowitz, M. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Hum. Mol. Genet. 14, 2387\u20132398 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnchembio466_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","volume":"134","author":"TW Mu","year":"2008","unstructured":"Mu, T.W. et al. Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 134, 769\u2013781 (2008).","journal-title":"Cell"},{"key":"BFnchembio466_CR16","doi-asserted-by":"publisher","first-page":"13813","DOI":"10.1073\/pnas.0605928103","volume":"103","author":"RA Steet","year":"2006","unstructured":"Steet, R.A. et al. The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms. Proc. Natl. Acad. Sci. USA 103, 13813\u201313818 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio466_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1021\/jm060677i","volume":"50","author":"Z Yu","year":"2007","unstructured":"Yu, Z., Sawkar, A.R., Whalen, L.J., Wong, C.H. & Kelly, J.W. Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention. J. Med. Chem. 50, 94\u2013100 (2007).","journal-title":"J. Med. Chem."},{"key":"BFnchembio466_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nchembio850","volume":"3","author":"RL Lieberman","year":"2007","unstructured":"Lieberman, R.L. et al. Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease. Nat. Chem. Biol. 3, 101\u2013107 (2007).","journal-title":"Nat. Chem. Biol."},{"key":"BFnchembio466_CR19","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1002\/cbic.200800249","volume":"9","author":"GJ Kornhaber","year":"2008","unstructured":"Kornhaber, G.J. et al. Isofagomine induced stabilization of glucocerebrosidase. ChemBioChem 9, 2643\u20132649 (2008).","journal-title":"ChemBioChem"},{"key":"BFnchembio466_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.bbrc.2008.02.125","volume":"369","author":"JS Shen","year":"2008","unstructured":"Shen, J.S., Edwards, N.J., Hong, Y.B. & Murray, G.J. Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase. Biochem. Biophys. Res. Commun. 369, 1071\u20131075 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnchembio466_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ymgme.2009.01.006","volume":"97","author":"B Liou","year":"2009","unstructured":"Liou, B. & Grabowski, G.A. Participation of asparagine 370 and glutamine 235 in the catalysis by acid beta-glucosidase: the enzyme deficient in Gaucher disease. Mol. Genet. Metab. 97, 65\u201374 (2009).","journal-title":"Mol. Genet. Metab."},{"key":"BFnchembio466_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/glycob\/cwn041","volume":"18","author":"BP Rempel","year":"2008","unstructured":"Rempel, B.P. & Withers, S.G. Covalent inhibitors of glycosidases and their applications in biochemistry and biology. Glycobiology 18, 570\u2013586 (2008).","journal-title":"Glycobiology"},{"key":"BFnchembio466_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1006\/abbi.1993.1353","volume":"304","author":"S Atsumi","year":"1993","unstructured":"Atsumi, S., Nosaka, C., Iinuma, H. & Umezawa, K. Accumulation of tissue glucosylsphingosine in Gaucher-like mouse induced by the glucosylceramidase inhibitor cyclophellitol. Arch. Biochem. Biophys. 304, 302\u2013304 (1993).","journal-title":"Arch. Biochem. Biophys."},{"key":"BFnchembio466_CR24","doi-asserted-by":"publisher","first-page":"10139","DOI":"10.1021\/jo051645q","volume":"70","author":"FG Hansen","year":"2005","unstructured":"Hansen, F.G., Bundgaard, E. & Madsen, R. A short synthesis of (+)-cyclophellitol. J. Org. Chem. 70, 10139 (2005).","journal-title":"J. Org. Chem."},{"key":"BFnchembio466_CR25","doi-asserted-by":"publisher","first-page":"29052","DOI":"10.1074\/jbc.M705005200","volume":"282","author":"B Brumshtein","year":"2007","unstructured":"Brumshtein, B. et al. Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanisms of chemical chaperone action in Gaucher disease. J. Biol. Chem. 282, 29052 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio466_CR26","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1515\/BC.2008.163","volume":"389","author":"Y Kacher","year":"2008","unstructured":"Kacher, Y. et al. Acid beta-glucosidase: insights from structural analysis and relevance to Gaucher disease therapy. Biol. Chem. 389, 1361\u20131369 (2008).","journal-title":"Biol. Chem."},{"key":"BFnchembio466_CR27","doi-asserted-by":"publisher","first-page":"26522","DOI":"10.1074\/jbc.273.41.26522","volume":"273","author":"HS Overkleeft","year":"1998","unstructured":"Overkleeft, H.S. et al. Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase. J. Biol. Chem. 273, 26522\u201326527 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio466_CR28","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.1046\/j.1432-1327.2000.01784.x","volume":"267","author":"JC Arribas","year":"2000","unstructured":"Arribas, J.C. et al. Differential mechanism-based labeling and unequivocal activity assignment of the two active sites of intestinal lactase\/phlorizin hydrolase. Eur. J. Biochem. 267, 6996\u20137005 (2000).","journal-title":"Eur. J. Biochem."},{"key":"BFnchembio466_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0304-4165(88)90030-X","volume":"964","author":"JM Aerts","year":"1988","unstructured":"Aerts, J.M. et al. Glucocerebrosidase, a lysosomal enzyme that does not undergo oligosaccharide phosphorylation. Biochim. Biophys. Acta 964, 303\u2013308 (1988).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnchembio466_CR30","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI116276","volume":"91","author":"S van Weely","year":"1993","unstructured":"van Weely, S. et al. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease. J. Clin. Invest. 91, 1167\u20131175 (1993).","journal-title":"J. Clin. Invest."},{"key":"BFnchembio466_CR31","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","volume":"273","author":"HH Chang","year":"2006","unstructured":"Chang, H.H., Asano, N., Ishii, S., Ichikawa, Y. & Fan, J.Q. Hydrophilic iminosugar active-sitespecific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients. FEBS J. 273, 4082\u20134092 (2006).","journal-title":"FEBS J."},{"key":"BFnchembio466_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1079-9796(03)00010-X","volume":"30","author":"B Rudensky","year":"2003","unstructured":"Rudensky, B. et al. Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease. Blood Cells Mol. Dis. 30, 97\u201399 (2003).","journal-title":"Blood Cells Mol. Dis."},{"key":"BFnchembio466_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1039\/B616590G","volume":"5","author":"TM Gloster","year":"2007","unstructured":"Gloster, T.M., Madsen, R. & Davies, G.J. Structural basis for cyclophellitol inhibition of a betaglucosidase. Org. Biomol. Chem. 5, 444\u2013446 (2007).","journal-title":"Org. Biomol. Chem."},{"key":"BFnchembio466_CR34","doi-asserted-by":"publisher","first-page":"14313","DOI":"10.1021\/ja036833h","volume":"125","author":"DL Zechel","year":"2003","unstructured":"Zechel, D.L. et al. Iminosugar glycosidase inhibitors: structural and thermodynamic dissection of the binding of isofagomine and 1-deoxynojirimycin to beta-glucosidases. J. Am. Chem. Soc. 125, 14313\u201314323 (2003).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchembio466_CR35","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1073\/pnas.1003247107","volume":"107","author":"CP Phenix","year":"2010","unstructured":"Phenix, C.P. et al. Imaging of enzyme replacement therapy using PET. Proc. Natl. Acad. Sci. USA 107, 10842\u201310847 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio466_CR36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/0003-2697(86)90043-6","volume":"154","author":"JMFG Aerts","year":"1986","unstructured":"Aerts, J.M.F.G. et al. A procedure for the rapid purification in high yield of human glucocerebrosidase using immunoaffinity chromatography with monoclonal antibodies. Anal. Biochem. 154, 655 (1986).","journal-title":"Anal. Biochem."},{"key":"BFnchembio466_CR37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1997)10:5<348::AID-HUMU3>3.0.CO;2-B","volume":"10","author":"RG Boot","year":"1997","unstructured":"Boot, R.G. et al. Glucocerebrosidase genotype of Gaucher patients in The Netherlands: Limitations in prognostic value. Hum. Mutat. 10, 348 (1997).","journal-title":"Hum. Mutat."},{"key":"BFnchembio466_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0006-2952(99)00384-6","volume":"59","author":"U Andersson","year":"2000","unstructured":"Andersson, U., Butters, T.D., Dwek, R.A. & Platt, F.M. N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo. Biochem. Pharmacol. 59, 821 (2000).","journal-title":"Biochem. Pharmacol."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nchembio.466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.466","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T15:49:10Z","timestamp":1684424950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchembio.466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,31]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFnchembio466"],"URL":"https:\/\/doi.org\/10.1038\/nchembio.466","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,31]]}}}